Pfizer Canada is investing $10 million over five years to create the Pfizer-FRSQ Innovation Fund to support research that has a high potential for tech transfer and commercialization in the short and medium terms. The fund will be managed by the Fonds de la recherche en santé du Québec (FRSQ) and is open to the province's 3,000 researchers in human health. Successful human health research projects must be large scale and involve several institutions and aim for concrete results that could lead to commercialization within three to five years. FRSQ hopes th